产品介绍 评论(0)
宿主来源
Mouse抗原名称
Rb (pS780)分子别名
Retinoblastoma-associated protein; p105-Rb; p110-RB1; pRb (Rb); pp110; RB1细胞定位
Cytoplasm, NucleusAccession
P06400克隆号
S-3521抗体类型
Mouse mAb抗体同种型
IgG1,k反应种属 ?
Hu阳性样本
Molt-4纯化方式
Protein G浓度
0.2 mg/ml标记
Alexa Fluor® 488性状
Liquid缓冲体系
PBS, 1% BSA, 0.3% Proclin 300
储存条件
12 months from date of receipt / reconstitution, 2 to 8 °C as supplied
应用
ICFCM
稀释度
应用 稀释度 推荐种属 ICFCM 5μl per million cells in 100μl volume Hu
Phospho-Rb (Ser780) refers to the specific modification state of the Retinoblastoma protein (Rb) phosphorylated at its serine 780 residue. The Rb protein is a critical negative regulator of the cell cycle. In its unphosphorylated or hypophosphorylated state, it binds to and inhibits the transcription factor E2F, thereby blocking cell cycle progression from the G1 phase to the S phase. When cells receive pro-proliferative signals, the cyclin-dependent kinase 4/6-cyclin D complex (CDK4/6-cyclin D) specifically catalyzes the phosphorylation of multiple sites on the Rb protein, including Ser780. Phosphorylation at Ser780 is an early and key event during G1 phase progression. It directly induces a conformational change in the Rb protein, causing its dissociation from E2F. Subsequently, E2F activates the transcription of a set of genes essential for S phase, driving DNA replication and cell cycle advancement. Therefore, the detection of Phospho-Rb (Ser780) levels is commonly used as an important molecular marker for assessing CDK4/6 kinase activity, cell proliferation status, and the G1/S transition. It is widely applied in cancer research (e.g., evaluating the efficacy of CDK4/6 inhibitors in breast cancer treatment) and studies on cell cycle regulatory mechanisms.
流式分析
Flow cytometric analysis of Human Rb expression on PMA-treated Molt-4. Molt-4 treated 24h with 200 ng/ml PMA (right panel) or untreated (left panel) were stained with SDT Alexa Fluor® 488 Mouse Anti-Human Rb Antibody at 5 μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.







评论(0)